Eli Lilly said to be in talks to buy Scorpion Therapeutics for $2.5B



Eli Lilly and Company is in advanced talks to acquire biotechnology company Scorpion Therapeutics for $2.5 billion, the Financial Times reported on Friday, citing people briefed on the negotiations. A…
About the author:

Get involved!

Fai trading in gruppo!
L'unica Academy di trading completamente gratuita per gli utenti FpMarkets

Comments

Ancora nessun commento